Hey orris this is Pardhu medical student final year emergency medicine student appearing for exams

Hey Pardhu! Welcome - great to have a final year emergency medicine student here. I'm Orris, and I'm well set up to help you prep for your exams.
I have access to a full medical textbook library, PubMed literature, and can cover clinical scenarios, pharmacology, procedures, ECG interpretation, trauma protocols, toxicology - whatever you need for EM.
What topic do you want to tackle first?

What are the high-yield EM topics for your exam?

Great question! Here are the classic high-yield Emergency Medicine topics that consistently appear in final year/postgraduate exams:

High-Yield Emergency Medicine Topics

1. Cardiovascular Emergencies

  • ACS - STEMI vs NSTEMI, Killip classification, thrombolytics vs PCI
  • Aortic dissection - Stanford/DeBakey classification, BP management
  • Cardiac tamponade - Beck's triad, pulsus paradoxus, emergency pericardiocentesis
  • Arrhythmias - AF, VT, VF, SVT - when to cardiovert vs defibrillate
  • Heart failure - acute pulmonary edema management

2. Respiratory Emergencies

  • Tension pneumothorax - needle decompression landmarks
  • Status asthmaticus - stepwise management, MgSO4 dosing
  • Pulmonary embolism - Wells score, PERC rule, massive PE management
  • ARDS - Berlin criteria, low tidal volume ventilation

3. Neurological Emergencies

  • Stroke - tPA window (4.5 hrs), NIHSS, hemorrhagic vs ischemic
  • Status epilepticus - Benzodiazepines → phenytoin → propofol/midazolam
  • Meningitis - empiric antibiotics (don't delay for LP), dexamethasone
  • Raised ICP - osmotherapy, head positioning, hyperventilation (temporizing)

4. Trauma

  • ATLS primary survey - ABCDE, permissive hypotension in penetrating trauma
  • Hemorrhagic shock - 4 classes, damage control resuscitation (1:1:1)
  • Head injury - GCS scoring, surgical thresholds (EDH vs SDH)
  • Spinal injury - NEXUS criteria, Canadian C-spine rule

5. Toxicology

  • Organophosphate poisoning - SLUDGE/DUMBELS, atropine + pralidoxime
  • Paracetamol overdose - Rumack-Matthew nomogram, NAC protocol
  • Opioid/Benzodiazepine overdose - reversal agents, doses
  • TCA overdose - sodium bicarb for wide QRS, avoid physostigmine
  • Digoxin toxicity - ECG changes, Fab fragments

6. Metabolic/Endocrine

  • DKA - diagnostic criteria, insulin protocol, K+ replacement pitfalls
  • Hyperosmolar state (HHS) - distinguishing from DKA
  • Adrenal crisis - hydrocortisone dosing
  • Thyroid storm - Burch-Wartofsky score, PTU vs methimazole, SSKI timing

7. Renal/Electrolytes

  • Hyperkalemia - ECG changes, calcium gluconate vs chloride, treatment ladder
  • Hyponatremia - correction rate (max 8-10 mEq/24h), ODS risk
  • Rhabdomyolysis - CK thresholds, aggressive IVF

8. Procedural/Airway

  • RSI - drug doses (succinylcholine vs rocuronium), failed airway algorithm
  • ACLS algorithms - VF/pVT, PEA/asystole, post-ROSC care
  • Ultrasound in EM - FAST exam, RUSH protocol, cardiac tamponade

9. Infectious/Sepsis

  • Sepsis-3 criteria - qSOFA, SOFA, fluid resuscitation bundles
  • Neutropenic fever - empiric antibiotic coverage
  • Necrotizing fasciitis - LRINEC score, surgical emergency

10. Obstetric Emergencies

  • Eclampsia - MgSO4 dosing, labetalol/hydralazine for BP
  • Ectopic pregnancy - beta-hCG discriminatory zone, methotrexate criteria
  • PPH - 4 T's (tone, tissue, trauma, thrombin), uterotonics

Exam Strategy Tips

  • Pattern questions are common: ECG + clinical scenario, toxidrome identification, "what do you do next?"
  • Know exact drug doses for: atropine, adenosine, epinephrine, amiodarone, labetalol, tPA
  • Scoring systems are frequently tested: GCS, NIHSS, Wells, CURB-65, Killip, Rankin
  • "Do first" questions - always think airway → breathing → circulation before specific treatment

Which of these areas do you want to deep-dive into? I can pull detailed content from the medical textbook library, clinical scenarios, or help you with specific MCQ-style questions on any topic.

Svt with abberacy

SVT with aberrancy is one of the classic "killer" ECG topics in EM exams - the core challenge is distinguishing it from VT, since the treatment is opposite.
Searching sources...
Reading File
Finding Sources
Finding Sources
Good hits. Let me pull the most relevant sections from Braunwald's, Frameworks for Internal Medicine, and the Washington Manual simultaneously.
Reading File
Reading File
Reading File
Good. Now let me get the Brugada criteria details and the Braunwald's morphology criteria (the most exam-relevant part):
Reading File
Reading File
Excellent content gathered. Let me now fetch the Brugada criteria flowchart image - it's extremely high yield visually:
Loading Image
Loading Image
Perfect. I now have everything needed for a complete, exam-focused answer. Here it is:

SVT with Aberrancy vs. VT - The High-Yield EM Breakdown

What is SVT with Aberrancy?

SVT with aberrancy = a supraventricular tachycardia (origin above the ventricles) that conducts through an abnormally functioning bundle branch, producing a wide QRS (>120 ms) on ECG.
Two distinct mechanisms:
  • SVT with baseline wide QRS - pre-existing fixed BBB (RBBB or LBBB present even in sinus rhythm)
  • SVT with aberrancy - "functional" block in a bundle branch that occurs only during tachycardia (rate-related, because one bundle branch hasn't finished repolarizing when the next impulse arrives)
The result on ECG looks identical to VT - both produce wide-complex tachycardia (WCT). This is the diagnostic dilemma.

Why Does It Matter in EM?

TreatmentSVT with AberrancyVT
AdenosineTerminatesMay work temporarily, can be used diagnostically
CCBs (verapamil)Safe, effectiveDANGEROUS - can cause haemodynamic collapse
Beta-blockersSafeDANGEROUS
Synchronized DCCVYes, if unstableYes, if unstable
AmiodaroneCan useFirst-line for stable VT
Golden Rule for EM exams: When in doubt, treat as VT. ~80% of WCT is VT. Giving verapamil to VT can kill the patient.

The Big Classification - Start Here

Tachycardia classification flowchart
Frameworks for Internal Medicine

ECG Features That Suggest VT (not SVT with Aberrancy)

Clinical context (most important)

  • Structural heart disease - prior MI, cardiomyopathy, cardiac surgery, infiltrative disease → strongly favors VT
  • Age >50 with CAD history → almost always VT
  • A young patient with no cardiac history, palpitations since childhood → more likely SVT with aberrancy

ECG features favoring VT

FeatureVTSVT with Aberrancy
AV dissociationPresent (pathognomonic)Absent
Fusion beatsPresentAbsent
Capture beatsPresentAbsent
QRS durationOften >160 msUsually 120-140 ms
QRS axisNorthwest (−90° to ±180°)Rarely northwest
Concordance (V1-V6)All positive or all negativeNot concordant
R to S nadir >100 ms in any precordial leadVTSVT
Transition wide→narrow at same rateAbsentSuggests SVT with aberrancy
  • AV dissociation = P waves marching through independently at a different rate from QRS = pathognomonic for VT
  • Fusion beat = partial capture of ventricle by sinus impulse merging with VT beat = proves AV dissociation = VT
  • Capture beat = sinus impulse completely captures the ventricle producing a narrow beat amid wide beats = VT

The Brugada Algorithm (Most Tested ECG Algorithm)

This is the standard validated stepwise approach:
Brugada criteria flowchart
Frameworks for Internal Medicine (adapted from Brugada P et al., Circulation 1991)
Step by step - if YES at any point → diagnose VT:
  1. Absence of RS complex in ALL precordial leads? → Yes = VT
  2. RS interval >100 ms in ANY precordial lead? → Yes = VT
  3. AV dissociation present? → Yes = VT
  4. Morphology criteria for VT in both V1-V2 AND V6? → Yes = VT
  5. If all 4 are NO → SVT with baseline wide QRS or SVT with aberrancy

Morphology Criteria in Detail (Step 4 of Brugada)

If RBBB pattern (R' in V1):

V1Favors VTFavors SVT
Monophasic R, qR, or RSTypical triphasic rSR' (rabbit ears with left ear taller)
V6QS or rS (R/S <1)qRS with R > S

If LBBB pattern (S in V1):

LeadFavors VTFavors SVT
V1R >30 ms wide, notched S downstroke, R to S nadir >60-70 msNarrow r, clean S
V6QS or QR (any Q wave)No Q wave

Other Causes of Wide-Complex Tachycardia (don't forget)

From Braunwald's Heart Disease:
  • Antidromic AVRT (WPW) - delta waves, accessory pathway conducts antegrade
  • Pre-excited AF - irregular, very fast, life-threatening - avoid AV nodal blockers
  • Hyperkalemia - sine wave pattern, no discrete P waves
  • Flecainide/class IC toxicity - drug-induced conduction slowing
  • Fascicular tachycardia - relatively narrow WCT, RBBB + left axis, responds to verapamil (exception to the rule)

EM Management Algorithm

Wide Complex Tachycardia
         |
    Haemodynamically unstable? (hypotension, shock, pulmonary oedema, chest pain)
         |
       YES → Synchronized DC cardioversion immediately
         |
        NO
         |
    Apply Brugada criteria + clinical context
         |
    VT likely (>80% chance) → IV Amiodarone 150 mg over 10 min, then 1 mg/min
         |
    SVT with aberrancy confirmed? → Adenosine 6 mg IV rapid push
         |
    Still uncertain? → Treat as VT (never give CCBs or beta-blockers)
Exam trap: Adenosine can be used diagnostically even in WCT - if it terminates the rhythm or transiently shows underlying SVT pattern, it confirms SVT with aberrancy. It will not harm VT (just transiently blocks AV node, may cause brief AV dissociation visible on monitor).

High-Yield Exam Summary

PointKey Fact
Most common cause of WCTVT (~80%)
Pathognomonic for VTAV dissociation + fusion/capture beats
Best ECG algorithmBrugada (4 steps)
Most dangerous drug errorVerapamil in VT
Safe default treatmentAmiodarone or synchronized DCCV
Fascicular tachycardia exceptionVerapamil-sensitive, RBBB + left axis
Pre-excited AFNever adenosine/digoxin/CCBs - use procainamide or DCCV
Sources: Frameworks for Internal Medicine; Braunwald's Heart Disease; Washington Manual of Medical Therapeutics

Want me to now do an MCQ-style question on this, or move to a related topic like pre-excited AF (WPW), or ACLS algorithms for WCT?

Pulmonary embolism and latest PE guidelines.?

PE is a top-tier EM exam topic. Let me pull both the textbook content AND latest guidelines simultaneously.
Searching sources...
Reading File
Searching PubMed

"pulmonary embolism" AND "guidelines"

Searching the Web

ESC pulmonary embolism guidelines 2024 2025 key changes

Excellent - there's a brand new 2026 AHA/ACC guideline (PMID 41712677)! Let me pull its abstract AND textbook content in parallel:
Reading Article

PMID: 41712677

Finding Sources
Reading Web Page

https://www.acc.org/latest-in-cardiology/ten-points-to-remem…

Now let me pull the textbook content directly with better search terms, and get the 2026 guideline details:
Finding Sources
Finding Sources
Reading Article

PMID: 40587333

Now let me pull the actual textbook content from Tintinalli's (EM-focused) and Murray & Nadel's for clinical details:
Reading File
Reading File
Let me grab the PERC rule details, the Wells score table, and Tintinalli's management section:
Reading File
Reading File
Let me get the management/treatment section from Tintinalli's:
Reading File
Now let me also grab the diagnostic flowchart image and the treatment section:
Reading File
Loading Image
I have everything needed for a comprehensive, exam-ready answer. Here it is:

Pulmonary Embolism - Complete EM Exam Guide + Latest 2026 Guidelines


🔴 BREAKING: 2026 AHA/ACC Guideline (Brand New!)

The 2026 AHA/ACC/ACCP/ACEP/CHEST guideline (published March 2026, PMID 41712677) is a completely de novo guideline - the most comprehensive update in years. Key new features:
  • Introduces the AHA/ACC Acute PE Clinical Categories (replaces older massive/submassive/low-risk terminology)
  • Strong recommendation for Pulmonary Embolism Response Teams (PERTs) as a new care standard
  • Encourages more outpatient management of low-risk PE
  • Addresses catheter-directed therapies more explicitly for intermediate/high-risk PE
The 2025 ESVM Guidelines (PMID 40587333) also provide updated recommendations on catheter-based therapy (CDT) and mechanical thrombectomy for VTE.

Classification - Start Here

Classic Classification (ESC-based, still widely used in exams)

CategoryDefinitionMortality
Massive (High-risk) PEHemodynamic instability: SBP <90 mmHg, or drop ≥40 mmHg for >15 min not due to other cause, or cardiac arrest>15%
Submassive (Intermediate-high risk) PEHemodynamically stable + RV dysfunction (echo/CTPA) + elevated troponin3-15%
Intermediate-low risk PEHemodynamically stable + only one of: RV dysfunction OR elevated biomarker<3%
Low-risk PENone of the above, PESI class I-II or sPESI = 0<1%

2026 AHA/ACC New PE Clinical Categories

The new guideline replaces "massive/submassive" with a tiered classification that combines hemodynamics + imaging + biomarkers to guide therapeutic decision-making more precisely (details pending full text publication).

Clinical Features

Classic triad (only in ~20% of patients):
  • Dyspnoea + Chest pain (pleuritic) + Haemoptysis
Common presentations:
  • Tachycardia (most sensitive sign)
  • Unexplained dyspnoea at rest or exertion
  • Pleuritic chest pain
  • Syncope (suggests massive PE with RV failure)
  • Signs of DVT (unilateral leg swelling)
ECG in PE (from Tintinalli's Emergency Medicine):
  • Sinus tachycardia (most common)
  • S1Q3T3 pattern (S wave in lead I, Q wave + T-wave inversion in lead III)
  • T-wave inversion V1-V4 (right heart strain)
  • Incomplete/complete RBBB
  • Right axis deviation
  • Note: normal ECG does NOT exclude PE; these findings increase probability
CXR (usually abnormal but nonspecific):
  • Cardiomegaly, basilar atelectasis, pleural effusion
  • Westermark's sign - focal oligaemia (hyperlucency from obstructed lobar artery) - <5%
  • Hampton's hump - peripheral wedge-shaped opacification (pulmonary infarction) - <5%
  • Normal CXR with hypoxaemia = high suspicion for PE

Risk Stratification Scores

Wells Score for PE (Original)

FactorPoints
Suspected DVT (clinical signs/symptoms)3
PE as likely or more likely than alternative diagnosis3
Heart rate >100 bpm1.5
Prior VTE (DVT or PE)1.5
Surgery or immobilization within prior 4 weeks1.5
Active malignancy1
Haemoptysis1
Interpretation:
  • 6 = High risk (78% probability of PE)
  • 2-6 = Moderate risk (28%)
  • <2 = Low risk (3.4%)
  • Dichotomous version: >4 = PE likely (go straight to CTPA); ≤4 = PE unlikely (D-dimer first)

PERC Rule (PE Rule-Out Criteria)

Use only if gestalt probability <15% (low suspicion). ALL 8 must be absent to rule out PE without further testing:
Criterion
Age ≥50 years
Pulse ≥100 bpm
SpO2 ≤94% on room air
Prior history of VTE
Surgery or trauma requiring anaesthesia within last 4 weeks
Haemoptysis
Exogenous estrogen use
Unilateral leg swelling
If PERC = 0 (all absent) → PE excluded. No D-dimer needed. If any 1 PERC criterion present → go to D-dimer/Wells pathway

sPESI (Simplified PESI) - for low-risk identification

1 point each for: Age >80, cancer, chronic cardiopulmonary disease, HR ≥110, SBP <100, SpO2 <90%
  • sPESI = 0 → low risk, consider early discharge/outpatient treatment

Diagnostic Algorithm

PE diagnostic flowchart based on Wells score, PERC, D-dimer, and CTPA
Symptom to Diagnosis, 4th Ed.
Key points:
  • Low probability (Wells 0-1): Check PERC → if 0, PE ruled out; if ≥1, D-dimer
  • Moderate probability (Wells 2-6): D-dimer → if negative, PE ruled out; if positive, CTPA
  • High probability (Wells ≥7): Go straight to CTPA

Age-Adjusted D-dimer (High Yield!)

For patients ≥50 years with low/intermediate probability:
  • Cutoff = Age × 10 µg/L (FEU units)
  • E.g., 70-year-old: D-dimer cutoff = 700 µg/L instead of 500 µg/L
  • Reduces unnecessary CTPA in elderly without sacrificing sensitivity

YEARS Algorithm (newer, increasingly used)

Three criteria: (1) clinical DVT signs, (2) haemoptysis, (3) PE most likely diagnosis
  • If 0 criteria: D-dimer threshold = 1000 µg/L
  • If ≥1 criterion: D-dimer threshold = 500 µg/L (standard)
  • If threshold exceeded → CTPA

Imaging

TestSensitivitySpecificityNotes
CTPA83-100%89-97%Gold standard, preferred first-line
V/Q scan~98% for normalLowerUse if contrast allergy, CKD, pregnancy
Bedside echo~60%~80%Detects RV strain - useful in unstable patients
Leg USS60-70%~97%If positive DVT → same treatment, no CTPA needed
D-dimer~95%40%High sensitivity, low specificity; rules OUT, not IN

Treatment

1. Hemodynamically Unstable (Massive/High-Risk PE)

Massive PE (shock/arrest)
    ↓
Immediate anticoagulation (heparin UFH bolus 80 U/kg IV)
    ↓
Systemic thrombolysis - FIRST LINE
  • Alteplase (tPA) 100 mg IV over 2 hours
  • For cardiac arrest: 50 mg rapid bolus
    ↓
If thrombolysis fails/contraindicated:
  • Catheter-directed therapy (CDT) or mechanical thrombectomy
  • Surgical embolectomy (last resort)
Contraindications to systemic thrombolysis (absolute):
  • Prior intracranial haemorrhage
  • Recent (<3 months) ischaemic stroke
  • CNS tumour/AVM
  • Recent (<3 months) head trauma/surgery
  • Active internal bleeding (not menses)

2. Hemodynamically Stable + RV Dysfunction (Submassive/Intermediate-High Risk)

  • Anticoagulation with LMWH or UFH
  • Do NOT give routine systemic thrombolysis (risk of major haemorrhage, especially ICH, outweighs benefit in stable patients)
  • Rescue thrombolysis if clinical deterioration occurs
  • CDT (catheter-directed thrombolysis at low dose, e.g., tPA 2 mg/hr via catheter) - may be considered in selected patients (high bleeding risk for systemic lysis)
  • PERT team consultation (per 2026 AHA/ACC guideline)

3. Low-Risk PE

  • Anticoagulation - DOACs preferred
  • Early discharge/outpatient treatment if sPESI = 0 and no other barriers (supported by 2026 AHA/ACC, ESC, CHEST)
  • Hestia criteria can also be used to identify suitability for home treatment

Anticoagulation - Drug Choice

AgentRegimenNotes
Rivaroxaban (DOAC)15 mg BD × 21 days → 20 mg ODPreferred first-line (no bridging needed)
Apixaban (DOAC)10 mg BD × 7 days → 5 mg BDPreferred first-line (no bridging)
LMWH + WarfarinLMWH until INR 2-3 for 2 consecutive daysUse in pregnancy, antiphospholipid syndrome, cancer
UFH80 U/kg bolus → 18 U/kg/hr infusionMassive PE, renal failure, high bleeding risk (easily reversible)
LMWH alone (cancer)Dalteparin, enoxaparinPreferred in malignancy
Duration of anticoagulation:
  • Provoked PE (reversible trigger - surgery, immobilisation): 3 months
  • Unprovoked PE or persistent risk factors: ≥3-6 months, consider extended therapy
  • Recurrent VTE or antiphospholipid syndrome: Indefinite

IVC Filter

Only indicated when:
  • Acute PE + absolute contraindication to anticoagulation
  • Does NOT reduce PE recurrence or mortality - all guidelines agree

Biomarkers in PE

BiomarkerRoleSignificance if elevated
Troponin (I or T)RV myocyte damageIntermediate/high risk, worse prognosis
BNP / NT-proBNPRV wall stressPoor prognosis, aids risk stratification
D-dimerFibrin degradationRules out (sensitive), not diagnostic
LactateTissue hypoperfusionIndicates haemodynamic compromise

Echo Findings in Massive PE

  • RV dilatation (RV:LV ratio ≥1.0 on echo or CTPA)
  • RV hypokinesis with sparing of the apex (McConnell's sign - RV free wall hypokinesis, apex normal)
  • Tricuspid regurgitation, elevated RVSP
  • TAPSE <16 mm (RV systolic dysfunction)
  • Paradoxical interventricular septal shift ("D-sign")
  • Thrombus in right heart

High-Yield Exam Summary Table

TopicKey Fact
Most common symptomDyspnoea
Most common signTachycardia
Most common ECG findingSinus tachycardia (S1Q3T3 in ~12%)
Gold standard imagingCTPA
Use PERC whenGestalt probability <15%, all 8 absent = no D-dimer
Age-adjusted D-dimerAge × 10 µg/L for patients ≥50
First-line treatment massive PESystemic alteplase 100 mg over 2h
First-line treatment low-risk PEDOAC (rivaroxaban or apixaban), early discharge
Avoid systemic thrombolysis inStable submassive PE (bleeding risk)
IVC filter indicationAbsolute CI to anticoagulation only
Minimum anticoagulation duration3 months (provoked)
PESI = 0 meansLow risk, suitable for outpatient treatment
McConnell's signRV free wall hypokinesis, apex spared = massive PE
Westermark's signFocal lung oligaemia on CXR
Hampton's humpPeripheral wedge density = pulmonary infarction
2026 AHA/ACC new conceptPE Clinical Categories + PERT team standard of care
Sources: Tintinalli's Emergency Medicine; Murray & Nadel's Respiratory Medicine; Symptom to Diagnosis, 4th Ed.; 2026 AHA/ACC PE Guideline, PMID 41712677; 2025 ESVM VTE Guideline, PMID 40587333

Want me to drill down on any section - e.g., massive PE resuscitation in detail, CTPA interpretation, catheter-directed therapies, or do some MCQs on PE?

All about pneumothorax for md emergency medicine exams

Pneumothorax is a classic EM exam topic - expect questions on tension PTX recognition, needle decompression landmarks, and BTS vs ACEP management differences.
Searching sources...
Finding Sources
Finding Sources
Searching PubMed

"pneumothorax" AND "management" AND "guidelines"

Excellent - there's a brand new 2024 ERS/EACTS/ESTS joint guideline (PMID 38806203). Let me pull everything in parallel:
Reading Article

PMID: 38806203

Finding Sources
Searching the Web

ERS EACTS ESTS 2024 spontaneous pneumothorax guidelines key recommendations management

Great - now let me pull the EM textbook content (Roberts & Hedges' Clinical Procedures in EM is gold for this) and Murray & Nadel's:
Reading File
Reading File
Now let me get the tension PTX/needle decompression section from Roberts & Hedges' (the EM procedures bible) and Tintinalli's:
Reading File
Reading File
Now let me fetch the key images - the zone of safety for chest tube, and the needle decompression sites:
Reading File
Reading File
Let me now grab the chest tube zone of safety image and the needle decompression diagram:
Reading File
Reading File
Let me now fetch the key procedural images:
Loading Image
Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC12362148

I have everything needed for a complete, exam-ready answer. Here it is:

Pneumothorax - Complete MD Emergency Medicine Guide


Classification

TypeDefinitionKey Features
Primary Spontaneous (PSP)No underlying lung diseaseYoung, tall, thin males; blebs/bullae
Secondary Spontaneous (SSP)Complicates lung diseaseCOPD (most common), asthma, TB, cystic fibrosis, PCP, Marfan's
TraumaticPenetrating or blunt chest traumaMay be occult on CXR (seen on CT)
IatrogenicProcedure-relatedSubclavian line, thoracentesis, positive pressure ventilation, CPR
TensionAir with one-way valve effectMedical emergency - obstructive shock
Open ("sucking chest wound")Chest wall defect communicates with atmospherePenetrating trauma

Pathophysiology

  • Normally, pleural pressure is negative (-3 to -5 cmH₂O) keeping the lung expanded
  • Air entry into pleural space → lung collapses (elastic recoil)
  • PSP: rupture of subpleural blebs/bullae at the apex → air enters with each breath
  • Tension PTX: one-way valve mechanism → air enters pleural space with each breath but cannot exit → progressive build-up → mediastinal shift → kinks SVC/IVC → obstructive shock → cardiac arrest

Clinical Features

Simple Pneumothorax

  • Sudden pleuritic chest pain (sharp, ipsilateral)
  • Dyspnoea (severity varies - mild in PSP, severe in SSP)
  • Tachycardia
  • Decreased breath sounds ipsilateral
  • Decreased chest expansion ipsilateral
  • Hyper-resonance on percussion ipsilateral

Tension Pneumothorax (the killer - diagnose clinically, DON'T wait for CXR!)

The classic teaching signs:
SignComment
TachycardiaEarly, sensitive
Hypotension / shockLate, indicates haemodynamic compromise
Absent breath sounds (ipsilateral)Reliable sign
Hyper-resonance (ipsilateral)Reliable sign
Tracheal deviation AWAY from affected sideLate and unreliable sign - may be absent
JVD (elevated JVP)Due to venous return obstruction
CyanosisVery late sign
Exam Trap: Tracheal deviation is a LATE sign and often ABSENT - do not wait for it! Treat on clinical suspicion. In ventilated patients: sudden rise in peak airway pressure + haemodynamic collapse = tension PTX until proven otherwise.

Diagnosis

CXR Findings

  • Absence of lung markings beyond the visceral pleural line
  • Visible pleural edge (white line)
  • Ipsilateral lung collapse
  • Tension PTX on CXR (if you choose to get one): tracheal deviation, mediastinal shift, depressed ipsilateral diaphragm, contralateral lung compression

Sizing on CXR

BTS method: measure rim of air at the hilum level
  • Small: <2 cm rim
  • Large: ≥2 cm rim
ACEP method: measure apex-to-cupola distance
  • Small: <3 cm
  • Large: ≥3 cm

CT Chest (gold standard for sizing and characterisation)

  • Detects occult PTX not visible on CXR
  • Identifies bullae/blebs, underlying lung disease
  • Measures PTX size accurately

POCUS (Point-of-Care Ultrasound) - High Yield for EM!

From Murray & Nadel's:
SignMeaning
Pleural sliding presentLung in contact with chest wall → RULES OUT PTX at that location
Absence of pleural slidingSuggests PTX (but not specific - also apnoea, adhesions)
"Seashore sign" (M-mode)Normal - granular pattern below pleural line = lung sliding
"Barcode/stratosphere sign" (M-mode)Absent sliding = A-line reverberation only = PTX
B-lines presentLung touching pleura → rules out PTX
Lung pointWhere sliding meets no-sliding = edge of PTX - highly specific for PTX
POCUS advantage over CXR: More sensitive (especially in supine trauma patients where air rises anteriorly and is missed on AP CXR). Lung point is pathognomonic.

Treatment - The EM Framework

STEP 1: Is it a TENSION pneumothorax?

Tension PTX (shock + absent breath sounds + hyper-resonance)?
                    |
                  YES
                    |
        Immediate decompression - DO NOT get CXR

STEP 2: Immediate Decompression for Tension PTX

Option A - Needle Decompression (Emergency temporising measure)
Two accepted sites:
SiteDetails
2nd ICS, midclavicular line (MCL)Traditional site; 14-16G angiocath
4th/5th ICS, midaxillary line (MAL)Preferred by ATLS and many EM guidelines - shorter skin-to-pleural distance, avoids internal mammary artery, fewer obese patient failures
  • Insert 14-16G angiocatheter perpendicular to chest wall, over the SUPERIOR border of the rib (avoids neurovascular bundle at inferior rib margin)
  • A rush of air confirms entry into pleural space
  • This converts tension → simple PTX → MUST follow with chest tube
Why MAL is now preferred: Cadaveric studies showed significantly shorter distance from skin to pleural space at 4th/5th ICS MAL vs 2nd ICS MCL, especially in obese patients where 2nd ICS MCL often fails (chest wall too thick for standard 14G needle)
Option B - Finger Thoracostomy (faster, more reliable - used by ATLS, pre-hospital)
  • Incision at 4th/5th ICS, MAL
  • Sharp dissection through ICS above the rib
  • Finger sweeps pleural space
  • Higher success than needle decompression; mandatory before chest tube in trauma

Zone of Safety for Chest Tube / Finger Thoracostomy

Zone of safety for chest tube placement - lateral chest wall triangle
Mulholland and Greenfield's Surgery
The "triangle of safety" is bounded by:
  • Anterior: Lateral border of pectoralis major
  • Inferior: Nipple line (men) / 2 fingerbreadths above inframammary fold (women)
  • Posterior: Anterior border of latissimus dorsi
Insert at 4th or 5th ICS in the midaxillary line, staying ABOVE the rib to avoid the neurovascular bundle.

Management of Simple/Spontaneous PTX

2024 ERS/EACTS/ESTS Guidelines - Major Paradigm Shift!

The 2024 joint ERS/EACTS/ESTS guideline (PMID 38806203) made 24 evidence-based recommendations. Key ones:
RecommendationStrength
Conservative management for minimally symptomatic, clinically stable PSP - regardless of sizeConditional
Needle aspiration OVER chest tube drain for initial PSP treatmentSTRONG
Ambulatory management (outpatient) for initial PSP treatmentConditional
Early surgical intervention for PSP in patients who prioritise recurrence preventionConditional
Autologous blood patch for SSP with persistent air leak (PAL)Conditional
Conservative management: Observe 4 hours in ED, confirm walking tolerance, arrange early follow-up. Only for PSP - NOT SSP.

BTS 2023 Guideline

  • Needle aspiration or tube drainage if patient unsuitable for conservative/ambulatory management
  • Recommends surgical pleurodesis + bullectomy for recurrence prevention

Full Management Algorithm

PNEUMOTHORAX
      |
 Haemodynamically unstable / Tension?
      |
     YES → Immediate needle decompression (4th/5th ICS MAL)
             → Followed by chest tube (same side)
      |
      NO
      |
   PRIMARY SPONTANEOUS (PSP)
      |
   Clinically stable, minimally symptomatic?
      |
     YES → CONSERVATIVE (2024 ERS guideline)
             Observe 4h, supplemental O2, early follow-up
             Regardless of size if stable
      |
      NO (symptomatic, large, or patient preference for treatment)
           |
        Needle aspiration FIRST (2024 ERS - STRONG recommendation)
           |
        Failed aspiration or SSP?
           |
        Chest tube (intercostal drain)
           |
        Pigtail catheter (8.3-14Fr) equally effective for pure PTX
        Large bore (≥28Fr) if haemothorax or large air leak
   
   SECONDARY SPONTANEOUS (SSP)
      → Almost always requires intercostal drain
      → More aggressive management due to limited respiratory reserve
      → Hospital admission mandatory
   
   TRAUMATIC
      → Drain all (chest tube) if PPV required
      → Small occult PTX (<3.5 cm) may be observed if stable, even on ventilator
      → Large (≥3.5 cm) or symptomatic → chest tube

Chest Tube Management

  • Drain connected to underwater seal ± suction (-20 cmH₂O)
  • Suction if persistent air leak or lung not re-expanding
  • Stop suction once air leak resolved → water seal only
  • Clamping trial before removal: clamp 4 hours → repeat CXR → remove if no re-accumulation
  • Pigtail catheter (Seldinger technique, 8-14Fr): equally effective for pure PTX, significantly less painful - now preferred for spontaneous PTX
  • From 2023 meta-analysis: pigtail vs large-bore chest tube - no difference in drainage success but significantly less pain with pigtail (PMID 36802811)

Recurrence Prevention

ApproachDetails
VATS (video-assisted thoracoscopic surgery)Gold standard for recurrence prevention; bullectomy + pleurodesis; lowest recurrence rates
Surgical pleurodesisChemical (talc) or mechanical (pleural abrasion)
Autologous blood patchFor persistent air leak in SSP - 2024 ERS conditional recommendation
Endobronchial valves (EBVs)Emerging; ~20% clear benefit; for PAL where air leak source identified
Recurrence rates:
  • After first PSP: 30-50% within 2 years
  • After second PTX: 50-80% chance of third
  • After VATS: < 5%
Indications for surgery at first episode:
  • Life-threatening tension PTX
  • Massive air leak / incomplete re-expansion
  • Air leak >4 days after second tube placed
  • Associated haemothorax with complications
  • Identifiable bullous disease
  • Patient preference (2024 ERS: early surgery acceptable option)
  • Bilateral simultaneous PTX
  • Occupation at risk (pilot, diver)

Open Pneumothorax ("Sucking Chest Wound")

  • Penetrating trauma creates chest wall defect > 2/3 tracheal diameter → air preferentially enters through wound (less resistance than trachea)
  • Immediate management: 3-sided occlusive dressing (Asherman seal or vented chest seal)
    • Seals 3 sides, leaves 4th open → acts as flutter valve (air out, not in)
    • A fully sealed dressing risks converting to tension PTX
  • Definitive: Formal chest tube (separate site from wound) + surgical repair of defect

Special Situations

PTX in Ventilated Patients

  • All PTX on PPV need drainage (even small ones - can rapidly tension)
  • Exception: small occult PTX ≤3.5 cm, stable patient - may observe with serial imaging

Iatrogenic PTX (post-subclavian/IJV line)

  • Small, asymptomatic: observe, supplemental O2
  • Symptomatic or enlarging: needle aspiration or chest tube

Haemopneumothorax

  • Large-bore chest tube (28-32Fr) mandatory
  • Drain blood to prevent empyema / fibrothorax

PTX in Pregnancy

  • Treat aggressively (SSP criteria); foetal hypoxia risk
  • VATS safe in pregnancy if needed

Bilateral PTX

  • Surgery indicated even at first episode

High-Yield Exam Summary

PointKey Fact
Most common cause PSPRuptured subpleural bleb; tall thin young male
Most common cause SSPCOPD
Most common iatrogenicSubclavian venous access
Tension PTX mechanismOne-way valve, progressive mediastinal shift, obstructive shock
Tension PTX most reliable signsAbsent breath sounds + hyper-resonance (NOT tracheal deviation - late/unreliable)
Needle decompression site4th/5th ICS midaxillary line (preferred) OR 2nd ICS MCL
Needle decompression gauge14-16G angiocatheter
"Over the rib" ruleAlways - avoid neurovascular bundle at inferior rib margin
Zone of safety4th/5th ICS, midaxillary line, within the lateral chest triangle
2024 ERS key changeConservative management for stable PSP regardless of size; needle aspiration STRONGLY preferred over chest tube
POCUS lung pointPathognomonic for PTX - edge of collapsed lung
POCUS barcode signAbsent pleural sliding = PTX
Pigtail vs large boreEqual efficacy for PTX, pigtail much less painful
Recurrence after first PSP30-50% within 2 years
Surgery indicationSecond PTX, persistent air leak >4 days, bilateral, occupation risk
Open PTX dressing3-sided vented seal (not 4-sided - risks tension)
Sources: Roberts and Hedges' Clinical Procedures in Emergency Medicine; Tintinalli's Emergency Medicine; Murray & Nadel's Respiratory Medicine; Mulholland & Greenfield's Surgery; 2024 ERS/EACTS/ESTS Guideline, PMID 38806203

Want me to do MCQ practice questions on pneumothorax, move on to haemothorax/chest trauma, or go deeper on any section?
This is a shared conversation. Sign in to Orris to start your own chat.